Surgical Science (UK) Today
| 0AAU Stock | 158.20 5.50 3.36% |
PerformanceInsignificant
| Odds Of DistressLow
|
Surgical Science is selling for under 158.20 as of the 27th of February 2025; that is 3.36 percent decrease since the beginning of the trading day. The stock's lowest day price was 158.2. Surgical Science has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. The performance scores are derived for the period starting the 28th of January 2025 and ending today, the 27th of February 2025. Click here to learn more.
Business Domain Commercial & Professional Services | Classification Industrials |
Surgical Science is entity of United Kingdom. It is traded as Stock on LSE exchange. More on Surgical Science Sweden
Moving together with Surgical Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Surgical Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Surgical Science's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Surgical Science or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President Development | Ran Bronstein |
| Business Concentration | Environmental & Facilities Services, Commercial & Professional Services, Industrials, Industrials, Commercial Services & Supplies, Commercial & Professional Services, Industrials (View all Sectors) |
Surgical Science Sweden (0AAU) is traded on London Exchange in UK and employs 274 people. Surgical Science is listed under Environmental & Facilities Services category by Fama And French industry classification. The company operates under Commercial Services & Supplies sector and is part of Industrials industry.
Check Surgical Science Probability Of Bankruptcy
Ownership AllocationOver half of Surgical Science's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Surgical Science Sweden. Please watch out for any change in the institutional holdings of Surgical Science as this could mean something significant has changed or is about to change at the company.
Check Surgical Ownership Details
Surgical Science Sweden Risk Profiles
Although Surgical Science's alpha and beta are two of the key measurements used to evaluate Surgical Science's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.82 | |||
| Semi Deviation | 2.97 | |||
| Standard Deviation | 3.42 | |||
| Variance | 11.71 |
Surgical Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Surgical Science without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
| All Next | Launch Module |
Surgical Science Corporate Management
Elected by the shareholders, the Surgical Science's board of directors comprises two types of representatives: Surgical Science inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Surgical. The board's role is to monitor Surgical Science's management team and ensure that shareholders' interests are well served. Surgical Science's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Surgical Science's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Inbal MazorBadichi | Executive Marketing | Profile | |
| Anna Ahlberg | Chief Officer | Profile | |
| Adv | Chief Officer | Profile | |
| Tom Englund | Chief Officer | Profile | |
| Daniel Evestedt | Head Development | Profile | |
| Jeffrey Berkley | Chief Officer | Profile |
Additional Tools for Surgical Stock Analysis
When running Surgical Science's price analysis, check to measure Surgical Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgical Science is operating at the current time. Most of Surgical Science's value examination focuses on studying past and present price action to predict the probability of Surgical Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgical Science's price. Additionally, you may evaluate how the addition of Surgical Science to your portfolios can decrease your overall portfolio volatility.